To further explore the function of METTL3 in RCC, we first validated the expression of METTL3 in RCC tissue samples and cell lines, indicating METTL3 expression was significantly lower in RCC samples compared with adjacent non-tumor samples. The gene discussed is METTL3; the disease is renal cell carcinoma.